A Clinical Trial Comparing Long Term Glycaemic Control of Insulin Degludec/Liraglutide (IDegLira) Versus Insulin Glargine Therapy in Subjects With Type 2 Diabetes Mellitus
A Clinical Trial Comparing Long Term Glycaemic Control of Insulin Degludec/Liraglutide (IDegLira) Versus Insulin Glargine Therapy in Subjects With Type 2 Diabetes Mellitus
This trial is conducted in Africa, Asia, Europe, North America and South America. The purpose is to compare long-term glycaemic control of insulin degludec/liraglutide (IDegLira) versus insulin glargine (IGlar) in insulin naïve subjects with type 2 diabetes mellitus inadequately controlled with oral anti diabetics.
Inclusion Criteria:
Exclusion Criteria:
CABA, C1179AAB, Argentina
Capital Federal, C1056ABJ, Argentina
Secunderabad, Andhra Pradesh 500003, India
Hoenefoss, 3515, Norway
Cosmo City, Gauteng 2188, South Africa
Angus, DD8 2AS, United Kingdom
Fife, KY14 6AW, United Kingdom